About Plus Medical

June 21, 2011, in Plus medical company weekly conference, Administrative vice manager, Mr. Jacky Deng said, recently, some workers always make little mistake, and that cause much remake, which is a...
Read more...
After 6 months Decoration, A new cleanroom workshop with4,000 sqm is complete in january 10, 2011, the cleanroom was retrofitted from a nonwoven products sewing room, it is located in the third floor...
Read more...
Plus Medical focuses on manufacturing safe and productive healthcare products, including of surgical apparel, gowns, drapes, and other Clinician and Patient protection products. All the time, we...
Read more...
November 16, 2010, Plus Medical took the road to Dusseldorf, German for participating in Medica World Forum for Medicine 2010. This time, Company have arranged four staff to take part in the fair,...
Read more...

Hot Products

  • Surgical Kits & Packs

    Surgical Kits & Packs

  • Surgical Drape

    Surgical Drape

  • Protective Products

    Protective Products

  • Surgical Gowns

    Surgical Gowns

  • Medical Materials

    Medical Materials

You are here:

Home News & Info Medical Industry News Research and Markets: Synthes Medical Device Company Intelligence Report 2011
Research and Markets: Synthes Medical Device Company Intelligence Report 2011 PDF Print
News & Information - Industry News
Written by Administrator   
Tuesday, 21 June 2011 10:38

DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Synthes Medical Device Company Intelligence Report" report to their offering.

Through its five product groups - Trauma, Spine, Craniomaxillofacial (CMF), Biomaterials and Power Tools - Synthes Inc develops and manufactures instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues, including both metallic and osteobiological materials. The group also has a power tools business.

Synthes Trauma produces plate and screw systems, intramedullary nailing systems and external fixation devices that are used for the surgical treatment of fractures, deformities and tumour diseases of long bones. The company also produces trauma implants for the shoulder, hand, pelvis, hip, condyles and foot.

 

The Synthes Spine portfolio covers products for the treatment of degenerative instabilities, fractures, tumours and deformities. The company offers a full range of solutions for the cervical, thoracic and lumbar spine.

The company's CMF systems offer a range of facial trauma, tumour resection and reconstructive implants and instruments. In August 2009, Synthes expanded beyond its core CMF business through an agreement with Kensey Nash to market and distribute the XCM (extra-cellular matrix) porcine dermis product for soft tissue reconstruction in ventral hernias and head and neck procedures.

 

Synthes' Biomaterials include a paste that can be used to fill bony defects; an implant for young children that resorbs after the body's bones have healed; and demineralised human bone that promotes bone healing. In May 2011, Synthes sold the Norian assets of its Biomaterials division to Kensey Nash.

Synthes Power Tools offers a range of air- and battery-driven drill systems, reamers and saws for use in orthopaedics and trauma surgery. In November 2010, this business was expanded with the acquisition of Anspach, which provided a complementary high-speed product line to the Synthes power tools portfolio.

Synthes is the world leader in traumatology, ranks among the top companies for spinal devices and is in the leading position in the CMF business.

In 2010, Synthes generated revenues of US$3.7 billion and net earnings of US$908 million. The company employs more than 11,400 people, mainly in the US, Switzerland, Germany, Austria and China.

Synthes Inc is registered in Delaware, US. Its holding company, Synthes GmbH, is based in Switzerland. Synthes Inc shares of common stock are listed on the SIX Swiss Exchange and included in the Swiss Market Index (SMI [FREE Stock Trend Analysis]) and are traded on SWX Europe, the SIX Swiss Exchange's blue chip trading platform in London. As of 31st December 2010, Dr h.c. mult. Hansjorg Wyss, Chairman of Synthes Inc, and Wyss family trusts held 40 and 8% of the company's shares, respectively.

 

This company report provides

  • Overview
  • Financial Review
  • Strategic Focus
  • Products
  • Manufacturing and Distribution
  • Agreements
  • Mergers, Acquisitions, Minority Investments and Divestments
  • Litigation
  • Key Corporate Events

For more information visit http://www.researchandmarkets.com/research/051418/synthes_medical_de

Source: Espicom Business Intelligence Ltd

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
This e-mail address is being protected from spambots. You need JavaScript enabled to view it



Read more: http://www.benzinga.com/press-releases/11/06/b1183588/research-and-markets-synthes-medical-device-company-intelligence-repor#ixzz1PuF0pQnK

 

Surgical apparel workshop

surgical apparel workshop

Sewing surgical gown seriously

sewing surgical gown seriously

Checking surgical drape

checking the surgical drape carefully

Detecting metal for products

detecing metal for medical products.jpg